Nutritional Supplements Delay the Progression of AIDS in HIV-Infected Patients not Receiving Antiretroviral Treatment According to the Harold Foster Foundation Business Wire
click here to return to Business Wire main menu
DonateNow





Nutritional Supplements Delay the Progression of AIDS in HIV-Infected Patients not Receiving Antiretroviral Treatment According to the Harold Foster Foundation

Business Wire - October 30, 2009


US AIDS Conference

SAN FRANCISCO - Data presented today from a 310 patient, 52 week, double-blind, controlled clinical trial demonstrates that a micronutrient supplement, Replenish+(TM) delays the progression of AIDS in HIV-infected patients not receiving antiretroviral treatment (ART).[1]

Replenish+(TM) formulated by study investigator Dr Harold Foster, delayed the progression of HIV to AIDS as observed by significant increases in CD4 counts, glutathione peroxidase levels, weight and quality of life parameters (as measured by Karnofsky scores).

The typical CD4 count for a healthy individual is between 500-1500 cells/ml2.[2] In HIV-positive patients not receiving ARVs, the CD4 count decreases on average between 50 to 100 cells/year.i However, the mean and median CD4 cell counts were approximately 120 cells/ml2 of blood higher than expected in HIV-positive patients not receiving ART after 52 weeks. After stopping nutritional supplements, dramatic declines in CD4 counts appear to have negated all the gains in quality of health that the patients had achieved during the nutritional phase of the trial.[3]

Dr James Sparling, MD, Internal Medicine and Respiratory Disease, Victoria, BC, Canada and study investigator said: "The improvements we observed in these patients are equivalent to what we have experienced in treating AIDS patients with ART at Mengo Hospital. We were amazed by the dramatic improvements in CD4 counts observed during the trial and it was a surprise to us that the counts fell so precipitately after Replenish+ was stopped. This data reveals the importance of nutritional supplementation for HIV infected patients."

Commenting on the trial results, Dr Edith Namulema, Principal Investigator, Program Manager HIV/AIDS, Mengo Hospital, Kampala, Uganda said: "It is evident that the local food stuffs consumed by our HIV patients are deficient of several minerals and micronutrients necessary for a good quality of life. This is partly due to the mineral deficiencies in the soils on which the food is grown. It is therefore important to regularly supplement the diets of HIV positive patients with these nutrients to improve the outcomes of their treatment."

Dr Harold Foster researched extensively into the specific nutrient deficiencies experienced by HIV/AIDS patients. For more information about Harold Foster's research, go to www.haroldfosterfoundation.org.

Poster presentation and interviews:

Dr Edith will be presenting this data on Friday 30th October from 2.30pm û 3.00pm and on Saturday 31st October from 2.15pm û 2.45pm. She is available for interviews during the conference. Please call Nicola Parry on 250 217 7586 or email on nparry@fosterhealth.ca to set up interviews.

1 Namulema E, Sparling, J & Foster, HD. Nutritional supplements can delay the progression of AIDS in HIV-infected patients: results from a double-blinded clinical trial at Mengo Hospital, Kampala, Uganda. J. Orthomol. Med., 2007; 22(3):129-36.

2 AIDS Meds. Com T-cell Test. http://www.aids-meds.com/articles/TCellTest_4727.shtml

3 Namulema, E, Sparling J, Foster, HD. When the nutritional supplements stop: Evidence from a double-blinded, HIV clinical trial at Mengo Hospital, Kampala, Uganda. J. Orthomol Med. 2008; 23(3):130-2.

Contacts

The Harold Foster Foundation

Nicola Parry, 250-217-7586

VP Marketing

nicci.parry@gmail.com
091030
BW091036


Copyright © 2009 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .